InsidersTradesSigma
Browse the full insider trade history of 에임드바이오, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 에임드바이오 has logged 3 reports. Market capitalisation: €2,136.4bn. The latest transaction was filed on 17 March 2026 — Sale. Among the most active insiders: 인터베스트. The full history is accessible without an account.
0 of 0 declarations